Stratified Medicine to Optimise the Treatment of Patients with Hepatitis C Virus Infection

  • no-js


STOP-HCV is a Medical Research Council (MRC) funded consortium which aims to use patient information to establish the most effective and cost effective treatments for patients with Hepatitis C Virus.


STOP-HCV Partners

The STOP-HCV consortium is formed of 21 partners representing academia, industry and the Hepatitis C Trust.

See partners >>

Latest News

Gilead Sciences BOSON study - exciting clinical results from the BOSON study - an academic/industrial collaboration within STOP-HCV have been published online (03 August 2015) in Gastroenterology

July/August 2015 - STOP-HCV researchers Dr John McLauchlan and Dr Graham Cooke comment on the work of STOP-HCV, and the current treatment landscape for HCV, in pieces published by the MRC and Medicine at Imperial.